Articles

Sulfated non-anticoagulant heparin derivative modifies intracellular hemoglobin, inhibits cell sickling in vitro, and prolongs survival of sickle cell mice under hypoxia

Division of Hematology, the Children’s Hospital of Philadelphia, Philadelphia, PA
The Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY, USA; Clinical Pathology (Hematology Section), Faculty of Medicine, Mansoura University, Mansoura
The Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY
The Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY
The Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY, USA; Vascular Vison Pharmaceuticals Co., 7 University Place, Rensselaer, NY
Haematologica Early view Feb 11, 2021 https://doi.org/10.3324/haematol.2020.272393